Tara Lech/thrombosis.org
Feb 21, 2026, 12:41
Tara Lech: New Guidelines for Comprehensive, Evidence Based Management of PE
Tara Lech, Director of Anticoagulation Services at Beth Israel Lahey Health and Member Board of Directors at Anticoagulation Forum, shared a post LinkedIn:
“New guidelines for comprehensive, evidence based management of PE
Collaborated on and endorsed by 8 societies
What you will find:
- Acute PE Clinical Categories (A-E)
- Clearly defined risk factors to screen for during a targeted history and physical examination
- Overview of an effective PERT Team
- LMWH preferred over unfractionated Heparin for most patients
- Considerations for special populations (Obesity, Thrombotic APS, Brain Tumors, CKD, Pregnancy, Breastfeeding, Chronic Liver Disease)
- Recommendations for timing and utility of LMWH levels, noting Class III
Recommendation: No Benefit for most patients with acute PE ”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation
-
Nov 8, 2026, 05:34Eugene Bolotin: Thrombosis and Survival in Pancreatic Cancer
-
Nov 8, 2026, 05:24Recognising Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding – RPTH Journal
-
Nov 8, 2026, 05:11WFH CCS 2027 Abstract Submission Now Open – World Federation of Hemophilia